AMMONIUM LACTATE Drug Patent Profile

When do Ammonium Lactate patents expire, and what generic alternatives are available?

Ammonium Lactate is a drug marketed by Padagis Israel, Sun Pharma Canada, and Watson Labs Inc. and is included in six NDAs.

The generic ingredient in AMMONIUM LACTATE is ammonium lactate. There are forty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ammonium lactate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ammonium Lactate

A generic version of AMMONIUM LACTATE was approved as ammonium lactate by PADAGIS ISRAEL on May 1^st, 2002.

Summary for AMMONIUM LACTATE

US Patents:	0
Applicants:	3
NDAs:	6

US Patents and Regulatory Information for AMMONIUM LACTATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Padagis Israel	AMMONIUM LACTATE	ammonium lactate	CREAM;TOPICAL	075774-001	May 1, 2002	AB	RX	No	No
Padagis Israel	AMMONIUM LACTATE	ammonium lactate	LOTION;TOPICAL	075570-001	Jun 23, 2004	AB	RX	No	Yes
Sun Pharma Canada	AMMONIUM LACTATE	ammonium lactate	CREAM;TOPICAL	075883-001	Apr 10, 2003	AB	RX	No	Yes
Watson Labs Inc	AMMONIUM LACTATE	ammonium lactate	CREAM;TOPICAL	076829-001	Feb 7, 2006		DISCN	No	No

AMMONIUM LACTATE Market Analysis and Financial Projection

Last updated: February 11, 2026

What Is the Investment Potential for Ammonium Lactate?

Ammonium lactate, primarily used in pharmaceutical and skincare formulations, is a topical agent for treating dry and hyperkeratotic skin conditions. Its commercial and R&D prospects depend on market demand, regulatory landscape, and potential patent protections.

Market Overview

The global topical pharmaceuticals market, valued at approximately $43.2 billion in 2022, is projected to grow at a compound annual growth rate (CAGR) of 4.5% through 2030 [1]. Ammonium lactate targets a niche within this sector, with applications in dermatology, primarily as a moisturizer and keratolytic agent.

Supply Chain and Manufacturing

Ammonium lactate is produced via fermentation of lactic acid, which is derived from carbohydrate fermentation. The raw materials are widely available, and production is established in multiple regions, including Asia, Europe, and North America.

Major players include:

• BASF
• Eastman Chemical Company
• Merck KGaA

Production costs are moderate, with bulk manufacturing benefiting from economies of scale. The pricing dynamics range from $3 to $8 per 100 grams in pharmaceutical-grade formulations, influencing margin potential.

Regulatory Landscape

Ammonium lactate’s regulatory status in the U.S. and E.U. is classified as an OTC (over-the-counter) dermatological ingredient, with no significant barriers to market entry when used within approved formulations.

Increased scrutiny on topical agents’ safety and efficacy, especially in pediatric populations and for chronic use, could influence market access.

R&D and Patent Environment

Currently, no patents cover the basic compound, meaning generic manufacturing is feasible. Innovation is centered on delivery systems and combination products, which may extend patent protection and create licensing opportunities.

Financial Fundamentals and Investment Risks

• Market Size & Growth: Limited but steady demand driven by skincare and dermatology markets.
• Profitability: Manufacturers report stable margins due to mature production processes.
• Regulatory Risks: Low for established uses; higher if new indications or formulations are developed.
• Competitive Risks: High for commoditized ingredients; innovation may be required for differentiation.
• Patent Expiry & Generics: Patent expiration has facilitated generics, reducing prices and margins.

Competitive Position and Strategies

Companies seeking investments should consider:

• Developing novel delivery systems (e.g., sustained-release formulations)
• Combining ammonium lactate with other actives for expanded indications
• Securing patents on formulations or delivery mechanisms to protect market share
• Engaging in regional regulatory approvals to expand market access

Key Takeaways

• Ammonium lactate is a mature ingredient in skincare with steady demand.
• Favorable production economics and moderate regulation support stable supply.
• Innovation primarily resides in formulation and delivery, not the compound itself.
• Patent expirations have enabled generics, reducing prices but increasing access.
• Investment opportunities are more compelling in companies developing novel formulations or expanding indications.

FAQs

1. What are the main applications of ammonium lactate?
   It is mainly used as a moisturizer and keratolytic agent in dermatology, treating dry skin, ichthyosis, and similar conditions.

2. How high is the risk of patent loss impacting profitability?
   The active compound is not patented, which increases competition from generics; innovation in formulations can mitigate margin erosion.

3. Are there regulatory hurdles for new formulations?
   No significant barriers for formulations that utilize existing approved ingredients. New indications may require clinical data and regulatory review.

4. What market regions show the most promise?
   North America and Europe maintain steady demand; emerging markets show increasing adoption driven by skincare awareness.

5. Is there ongoing R&D for ammonium lactate?
   Most innovation focuses on combining it with other actives or improving delivery systems rather than the active itself.

References

[1] MarketWatch. (2022). Topical dermatological products market. https://www.marketwatch.com